159 related articles for article (PubMed ID: 11064900)
21. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
22. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
23. [Nerve sparing retroperitoneal lymphadenectomy with intraoperative electrostimulation in patients with nonseminomatous testicular tumors].
Huland H; Dieckmann KP; Sauerwein D
Urologe A; 1992 Jan; 31(1):1-7. PubMed ID: 1313195
[TBL] [Abstract][Full Text] [Related]
24. [Antegrade ejaculation after modified lumboaortic laparoscopic lymphadenectomy].
Valero Fuentealba G
Arch Esp Urol; 2008 May; 61(4):517-20. PubMed ID: 18592770
[TBL] [Abstract][Full Text] [Related]
25. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
26. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
[TBL] [Abstract][Full Text] [Related]
27. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
[TBL] [Abstract][Full Text] [Related]
28. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
29. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer.
Subramanian VS; Nguyen CT; Stephenson AJ; Klein EA
Urol Oncol; 2010; 28(5):504-9. PubMed ID: 19097812
[TBL] [Abstract][Full Text] [Related]
30. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
Mosharafa AA; Foster RS; Koch MO; Bihrle R; Donohue JP
J Urol; 2004 May; 171(5):1839-41. PubMed ID: 15076289
[TBL] [Abstract][Full Text] [Related]
31. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
[TBL] [Abstract][Full Text] [Related]
32. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
[TBL] [Abstract][Full Text] [Related]
33. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
[TBL] [Abstract][Full Text] [Related]
34. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
[TBL] [Abstract][Full Text] [Related]
35. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
[TBL] [Abstract][Full Text] [Related]
36. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Becht E
Urology; 2006 Jul; 68(1):154-60. PubMed ID: 16820195
[TBL] [Abstract][Full Text] [Related]
37. [Retroperitoneal lymphadenectomy and disorders of ejaculation].
Deiana G; Ranieri A; Micheli E; Peracchia G; Canclini LP; Sironi D; Levorato CA; Lembo A
Arch Ital Urol Androl; 1999 Sep; 71(4):241-4. PubMed ID: 10592539
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
39. Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcome.
Tanaka T; Kitamura H; Kunishima Y; Takahashi S; Takahashi A; Masumori N; Itoh N; Tsukamoto T
Jpn J Clin Oncol; 2006 Jun; 36(6):381-6. PubMed ID: 16762970
[TBL] [Abstract][Full Text] [Related]
40. [Transperitoneal laparoscopic modified lymph node dissection for clinical stage I nonseminomatous germ cell testicular carcinoma].
Wu HY; Zhang DH; Li XD; Ding GQ; Chen YB
Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1118-20. PubMed ID: 19157236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
